Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -149,034 | -96,130 | -49,498 | -260,602 | -217,310 |
| Depreciation Amortization | 1,066 | 762 | 383 | 1,563 | 1,180 |
| Accounts receivable | -13,745 | -7,145 | 687 | -3,645 | -4,439 |
| Accounts payable and accrued liabilities | 20,637 | 9,622 | -3,633 | 21,918 | 6,739 |
| Other Working Capital | -277 | -3,384 | -7,909 | 10,575 | 367 |
| Other Operating Activity | 51,067 | 32,611 | 19,619 | 116,312 | 118,429 |
| Operating Cash Flow | $-90,286 | $-63,664 | $-40,351 | $-113,879 | $-95,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -127,500 | 78,847 | 24,812 | -7,673 | -28,830 |
| PPE Investments | -40,000 | N/A | N/A | -40,500 | -40,500 |
| Investing Cash Flow | $-167,500 | $78,847 | $24,812 | $-48,173 | $-69,330 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14,517 | -8,947 | -4,615 | -12,900 | -9,092 |
| Common Stock Issued | 201,393 | 6,523 | 3,080 | 56,392 | 14,256 |
| Other Financing Activity | 34,035 | 34,034 | 34,034 | 147,750 | 147,750 |
| Financing Cash Flow | $220,911 | $31,610 | $32,499 | $191,242 | $152,914 |
| Exchange Rate Effect | 23 | -281 | -2 | 2 | -975 |
| Beginning Cash Position | 89,601 | 89,601 | 89,601 | 60,409 | 60,409 |
| End Cash Position | 52,749 | 136,113 | 106,559 | 89,601 | 47,983 |
| Net Cash Flow | $-36,852 | $46,512 | $16,958 | $29,192 | $-12,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,286 | -63,664 | -40,351 | -113,879 | -95,034 |
| Capital Expenditure | -40,000 | 0 | 0 | -40,500 | -40,500 |
| Free Cash Flow | -130,286 | -63,664 | -40,351 | -154,379 | -135,534 |